Conditional loss of PTEN leads to skeletal abnormalities and lipoma formation

Molecular Carcinogenesis

Volumn 48, Issue 6, 2009, Pages 545-552

  Hsieh, Shu Chen ^a   Chen, Nien Tsu ^a   Su, Hao Lo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cartilage; Lipoma; PTEN; Spine

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRODESIS; ARTICLE; CARTILAGE CELL; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; GENE DELETION; GROWTH PLATE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; INTERVERTEBRAL DISK; KYPHOSIS; LIPID STORAGE; LIPOMA; LONG BONE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKELETON MALFORMATION; TRABECULAR BONE; VERTEBRA; WESTERN BLOTTING; X RAY FILM;

ANIMALS; BONE AND BONES; CHONDROCYTES; ENZYME ACTIVATION; LIPOMA; MALE; MICE; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE;

MUS;

EID: 65749093920     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20491     Document Type: Article

References (26)

1. Dahia PL. PTEN, a unique tumor suppressor gene. Endocr Relat Cancer 2000;7:115-129. (Pubitemid 30609989)
2. Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-67.
3. Marsh DJ, Dahia PL, Zheng Z, et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 1997;16:333-334.
4. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998;280: 1614-1617. (Pubitemid 28277707)
5. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998;273:13375-13378. (Pubitemid 28268370)
6. Stiles B, Groszer M, Wang S, Jiao J, Wu H. PTENless means more. Dev Biol 2004;273:175-184. (Pubitemid 39144393)
7. Rosivatz E. Inhibiting PTEN. Biochem Soc Trans 2007;35: 257-259.
8. Stambolic V, Suzuki A, de la Pompa JL, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998;95:29-39.
9. Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005;24:7455-7464. (Pubitemid 41637985)
10. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003;423:332-336. (Pubitemid 40852707)
11. de Crombrugghe B, Lefebvre V, Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol 2001;13:721-727. (Pubitemid 33048841)
12. Iannone FC, De Bari C, Scioscia C, Patella V, Lapadula G. Increased Bcl-2/p53 ratio in human osteoarthritic cartilage:A possible role in regulation of chondrocyte metabolism. Ann Rheum Dis 2005;64:217-221.
13. Schedel J, Distler O, Woenckhaus M, et al. Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis. Ann Rheum Dis 2004;63: 1205-1211.
14. Pfander D, Kobayashi T, Knight MC, et al. Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development 2004;13:2497-2508.
15. Kuorilehto T, Ekholm E, Nissinen M, et al. NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis. J Histochem Cytochem 2006;54:363-370.
16. Laws N, Hoey A. Progression of kyphosis in mdx mice. J Appl Physiol 2004;97:1970-1977. (Pubitemid 39426018)
17. Liao YC, Si L, deVere White RW, Lo SH. The phosphotyrosineindependent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1. J Cell Biol 2007;176:43-49.
18. Ovchinnikov DA, Deng JM, Ogunrinu G, Behringer RR. Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis 2000;26: 145-146. (Pubitemid 30158102)
19. Ford-Hutchinson AF, Ali Z, Lines SE, Hallgrimsson B, Boyd SK, Jirik FR. Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth. J Bone Miner Res 2007;22:1245-1259.
20. Pereira IR, Draznin B. Inhibition of the phosphatidylinositol 3′-kinase signaling pathway leads to decreased insulin-stimulated adiponectin secretion from 3T3-L1 adipocytes. Metabolism 2005;54:1636-1643. (Pubitemid 41728157)
21. Aubin D, Gagnon A, Sorisky A. Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture. Int J Obes (Lond) 2005;29:1006-1009. (Pubitemid 41076243)
22. Nakashima N, Sharma PM, Imamura T, Bookstein R, Olefsky JM. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem 2000;275: 12889-12895. (Pubitemid 30241444)
23. Stiles B, Wang Y, tahl A, et al. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci USA 2004; 101:2082-2087.
24. Horie Y, Suzuki A, Kataoka E, et al. Hepatocytespecific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest 2004;113:1774-1783.
25. Kurlawalla-Martinez C, Stiles B, Wang Y, Devaskar SU, Kahn BB, Wu H. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol 2005;25:2498-2510. (Pubitemid 40354642)
26. Gil EB, Link EM, Liu LX, Johnson CD, Lees JA. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc Natl Acad Sci USA 1999;96:2925-2930. (Pubitemid 29148820)